Glenmark Pharmaceuticals Ltd reported a net profit of ₹347.9 crore for Q3 FY25 as compared to a net loss of ₹351.3 crore in the third quarter of last fiscal. Revenue from operations jumped ...

Drugmaker Glenmark Pharmaceuticals clocked a consolidated ... Strengthening our value-chain strategy, we secured MHRA authorization for Winlevi in the UK, marking a pivotal step in expanding ...

Feb 14 (Reuters) - India's Glenmark Pharmaceuticals (GLEN.NS), opens new tab reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Glenmark Pharmaceuticals Ltd. is a research-led, global pharmaceutical company, having a presence across branded, generics, and OTC segments; with a focus on therapeutic areas of respiratory, ...

(Reuters) - India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs. The drugmaker reported a consolidated net ...

Glenmark Pharmaceuticals reported a net profit of Rs 348 crore for Q3FY25, a significant turnaround from a Rs 351 crore loss ...

1 Glenmark's Clindamycin Phosphate Foam, 1% is only approved for the indication(s) listed in Glenmark's approved label. 2 All brand names and trademarks are the property of their respective owners.

with the pharmaceutical industry particularly at risk due to an extensive and international supply chain. From chemicals to API manufacturing, formulation, packaging, and drug delivery to the ...

All public health activities and operations depend on an effective supply chain, making resilience and capacity-building vital for health outcomes. With pharmaceutical supply chains becoming ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Warehouse operations face unprecedented challenges, including rising labor costs, low unemployment, fluctuating demand, and increasing customer expectations across B2B and B2C channels. Traditional ...